Can dialyzer membrane selection affect outcomes in patients with acute kidney injury requiring dialysis?

Hemodialysis International

Volumn 13, Issue SUPLL. 1, 2009, Pages

  Davenport, Andrew ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Acute kidney injury; Dialyzer membrane biocompatibility; Dialyzer membranes

Indexed keywords

AUTACOID; BRADYKININ;

ACUTE DISEASE; ARTICLE; ARTIFICIAL KIDNEY; CLINICAL PROTOCOL; COMORBIDITY; DIALYSIS; DISEASE EXACERBATION; GEOMETRY; HUMAN; HYDRAULIC PERMEABILITY; HYPOTENSION; INSTRUMENT STERILIZATION; KIDNEY INJURY; MEMBRANE; SOLUTE; SURVIVAL; ULTRAFILTRATION;

HUMANS; KIDNEY FAILURE, ACUTE; MEMBRANES, ARTIFICIAL; RENAL DIALYSIS;

EID: 70349983058     PISSN: 14927535     EISSN: 15424758     Source Type: Journal    
DOI: 10.1111/j.1542-4758.2009.00413.x     Document Type: Article

References (33)

1. Davenport A. Intradialytic complications during haemodialysis. Hemodial Int 2006, 10:162-167.
2. Liu YL, Prowle J, Licari E, Uchino S, Bellomo R. Changes in blood pressure before the development of nosocomial acute kidney injury. Nephrol Dial Transplant 2009, 24:504-511.
3. Augustine JJ, Sandy D, Seifert TH, Paganini EP. A randomized controlled trial comparing intermittent with continuous dialysis in patients with ARF. Am J Kidney Dis 2004, 44:1000-1007.
4. Uchino S, Bellomo R. Patient and kidney survival by dialysis modality in critically ill patients with acute kidney injury. Int J Artif Organs 2007, 30:281-292. Beginning and Ending Supportive Therapy for the Kidney (B.E.S.T. Kidney) Investigators Writing Committee
5. Craddock PR, Fehr J, Brigham KL, Kronenberg RS, Jacob HS. Complement and leukocyte-mediated pulmonary dysfunction in hemodialysis. N Engl J Med 1977, 296:769-774.
6. Kaplow LS, Goffinet JA. Profound neutropenia during the early phase of hemodialysis. JAMA 1968, 203:1135-1137.
7. Hakim RM, Wingard RL, Parker RA. Effect of the dialysis membrane in the treatment of patients with acute renal failure. N Engl J Med 1994, 331:1338-1342.
8. Schiffl H, Lang SM, König A, Strasser T, Haider MC, Held E. Biocompatible membranes in acute renal failure. Lancet 1994, 27:570-572.
9. Liaño F, Pascual J. Epidemiology of acute renal failure. Kidney Int 1996, 50:811-818.
10. Jörres A, Gahl GM, Dobis C. Hemodialysis-membrane biocompatibility and mortality of patients with dialysis-dependent acute renal failure. Lancet 1999, 354:1337-1341.
11. Jaber BL, Lau J, Schmid CH, Karsou SA, Levey AS, Pereira BJ. Effect of biocompatibility of hemodialysis membranes on mortality in acute renal failure. Clin Nephrol 2002, 57:274-282.
12. Subramanian S, Venkataraman R, Kellum JA. Influence of dialysis membranes on outcomes in acute renal failure. Kidney Int 2002, 62:1819-1823.
13. Alonso A, Lau J, Jaber BL. Biocompatible hemodialysis membranes for acute renal failure. Cochrane Database Syst Rev 2008, 23. CD005283
14. Palevsky PM, Zhang JH. Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med 2008, 359:7-20. VA/NIH Acute Renal Failure Trial Network
15. Davenport A, Bouman C, Kirpalani A. Delivery of Renal Replacement Therapy in acute kidney injury. Clin J Am Soc Nephrol 2008, 3:887-894.
16. Davenport A. The brain and the kidney-organ cross talk and interactions. Blood Purif 2008, 26:526-536.
17. Davenport A. Practical guidance for dialyzing a haemodialysis patient following acute brain injury. Hemodial Int 2008, 12:307-312.
18. Gibney N, Cerda J, Davenport A. Volume management by renal replacement therapy in acute kidney injury. Int J Artif Organs 2008, 31:145-155.
19. Gastaldello K, Melot C, Kahn RJ, Vanherweghem JL, Vincent JL, Tielemans C. Comparison of cellulose diacetate and polysulfone membranes in the outcome of acute renal failure. A prospective randomized study. Nephrol Dial Transplant 2000, 15:224-230.
20. Davenport A. The role of dialyzer membrane flux in bio-incompatibility. Hemodial Int 2008, 12((Suppl 2)):S29-S33.
21. Davenport A. Pyrexia of unknown origin in a haemodialysis patient. NDT Plus 2008, 1:109-111.
22. Opatrny K. Clinical importance of biocompatibility and its effect on haemodialysis treatment. Nephrol Dial Transplant 2003, 18((Suppl 5)):v41-v44.
23. Ebo DG, Bosmans JL, Couttenye MM, Stevens WJ. Hemodialysis-associated anaphylactic and anaphylactoid reactions. Allergy 2006, 61:211-220.
24. Davenport A, Will EJ, Davison AM. Are changes in intracranial pressure during intermittent machine haemofiltration dependent upon biocompatibility?. Int J Artif Organs 1989, 12:703-707.
25. Davenport A, Davison AM, Will EJ. Does membrane biocompatibility effect cardiovascular stability in critically ill patients treated by machine hemofiltration?. Kid Int 1993, 43((Suppl 41)):S230-S234.
26. Stoves J, Goode NP, Visvanathan R. The bradykinin response and early hypotension at the introduction of continuous renal replacement therapy in the intensive care unit. Artif Organs 2000, 25:1009-1021.
27. Coppo R, Amore A, Cirina P. Bradykinin and nitric oxide generation by dialysis membranes can be blunted by alkaline rinsing solutions. Kidney Int 2000, 58:881-888.
28. Simmons EM, Himmelfarb J, Sezer MT. Plasma cytokine levels predict mortality in patients with acute renal failure. Kidney Int 2004, 65:1357-1365.
29. Haase M, Bellomo R, Morgera S, Baldwin I, Boyce N. High cut-off point membranes in septic acute renal failure. Int J Artif Organs 2007, 30:1031-1041.
30. Hutchison CA, Harding S, Mead G. Serum free-light chain removal by high cutoff hemodialysis. Artif Organs 2008, 32:910-917.
31. Davenport A. Can modification of renal replacement therapy improve the outcome of patients with systemic inflammatory response syndrome?. Blood Purif 2006, 24:317-318.
32. Rimmelé T, Assadi A, Cattenoz M. High volume hemofiltration with a new haemofiltration membrane having enhanced adsorption properties in septic pigs. Nephrol Dial Transplant 2009, 24:421-427.
33. Chanard J, Lavaud S, Maheut H, Kazes I, Vitry F, Rieu P. The clinical evaluation of low-dose heparin in haemodialysis. Nephrol Dial Transplant 2008, 23:2003-2009.